Industry News

Perrigo Confirms First to File Patent Challenge for Generic Version of Aveed� (Testosterone Undecanoate) Injection
BioSyent Pharma Launches New Proktis-M(R) Suppositories
Bracco Diagnostics Inc. Creates First and Only U.S. FDA-Approved Multi-Dose Compliant Contrast Medium as Breakthrough Solution for Point-of-Care Use in the CT Suite
PetVivo Announces Definitive Merger Agreement with Gel-Del Technologies
IGI Laboratories, Inc. Announces ANDA Submission
UPDATE: Insys Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol As A Potential Treatment For Pediatric Schizophrenia
Merck and NewLink Genetics Enter Into Licensing and Collaboration Agreement for Investigational Ebola Vaccine
Endo Acquires Rights to Natesto� Testosterone Nasal Gel
FDA issues additional guidance for outsourcing facilities that compound sterile human drugs
CMDh agrees to strengthen warnings on the use of valproate medicines in women and girls; Women to be better informed of risks of valproate use in pregnancy and need for contraception
Beximco Gets Good Manufacturing Practices Approval In Canada
BioMarin and Prosensa Holding N.V. Reach Agreement on Intended Public Offer for 100% of Prosensa's Outstanding Stock; Will Add Duchenne Muscular Dystrophy Products to Rare-Disease Portfolio
Actamax Updates on Results of Novel Adhesion Barrier Device Trial
Actavis to Buy Botox-Maker Allergan for $66 Billion
Soaring generic drug prices draw Senate scrutiny
U.S. FDA Grants Fast Track Designation to Novavax' RSV F-Protein Nanoparticle Vaccine for Protection of Infants Via Maternal Immunization
GlaxoSmithKline Reports EU Regulatory Submission for Severe Aplastic Anemia Indication for Revolade
Shire To Cut Costs With US Site Consolidation, Appoints Interim CFO
Aurora Spine Receives FDA 510(k) Clearance for Pre-Packaged Sterile ZIP 51(TM) MIS Interspinous Fixation Implant
Actavis to Buy Botox-Maker Allergan for $66 Billion
Shire To Cut Costs With US Site Consolidation, Appoints Interim CFO
Bristol-Myers Squibb to Construct a New Large-Scale Biologics Manufacturing Facility in Cruiserath, Ireland
Merck KGaA, Darmstadt, Germany, Announces Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology
Merck KGaA, Darmstadt, Germany, Announces Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology
GlaxoSmithKline Reports EU Regulatory Submission for Severe Aplastic Anemia Indication for Revolade